Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eisai CO Ltd ADR (ESALY)

Eisai CO Ltd ADR (ESALY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 14,569,541
  • Shares Outstanding, K 286,520
  • Annual Sales, $ 5,786 M
  • Annual Income, $ 570,470 K
  • 60-Month Beta 0.26
  • Price/Sales 2.44
  • Price/Cash Flow 17.40
  • Price/Book 2.46
  • Price/Earnings ttm 21.63
  • Earnings Per Share ttm 2.28
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/07/19
  • Annual Dividend & Yield 1.22 (2.40%)
  • Most Recent Dividend 0.611 on 03/26/19
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.59
  • Number of Estimates 1
  • High Estimate 0.59
  • Low Estimate 0.59
  • Prior Year 0.64
  • Growth Rate Est. (year over year) -7.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.8700 +3.93%
on 09/18/19
52.9300 -4.04%
on 09/26/19
-0.2400 (-0.47%)
since 09/13/19
3-Month
48.5200 +4.68%
on 09/04/19
56.0700 -9.42%
on 07/15/19
-5.3200 (-9.48%)
since 07/12/19
52-Week
48.5200 +4.68%
on 09/04/19
96.1600 -47.18%
on 10/19/18
-40.5450 (-44.39%)
since 10/12/18

Most Recent Stories

More News
Xencor (XNCR) Jumps: Stock Rises 7.4%

Xencor (XNCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

XNCR : 34.71 (+0.32%)
ESALY : 50.7900 (-0.12%)
The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

MLM : 265.69 (+0.10%)
ESALY : 50.7900 (-0.12%)
COLM : 98.25 (-0.10%)
Ocular (OCUL) Gets FDA Nod for Label Expansion of Dextenza

Ocular (OCUL) clinches the FDA approval for the label expansion of Dextenza to treat ocular inflammation following ophthalmic surgery.

REGN : 307.71 (+2.31%)
AERI : 20.04 (-0.55%)
OCUL : 3.08 (+4.76%)
ESALY : 50.7900 (-0.12%)
Pape Diop propose des formes de financements innovants

"Les communes et autres collectivités locales doivent réfléchir sur les modalités d'augmenter leur budget en recourant à des financements innovants", a dit samedi à Louga, Pape Diop.

CannTrust Holdings (CTST) in Focus: Stock Moves 6.1% Higher

CannTrust Holdings (CTST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ESALY : 50.7900 (-0.12%)
CTST : 0.82 (-10.87%)
Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start

Catalyst (CPRX) posts narrower-than-expected loss and beats on revenues in the first quarter of 2019.

BSTC : 50.17 (-0.14%)
CPRX : 5.03 (+4.14%)
REPH : 11.06 (+0.09%)
ESALY : 50.7900 (-0.12%)
Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss

Zoetis???s (ZTS) earnings beat estimates but sales miss the same in the first quarter of 2019.

ZTS : 127.21 (-0.98%)
ESALY : 50.7900 (-0.12%)
FGEN : 37.44 (+0.40%)
BSTC : 50.17 (-0.14%)
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%

Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement.

ESALY : 50.7900 (-0.12%)
BSTC : 50.17 (-0.14%)
AKAO : 0.11 (unch)
ASRT : 1.10 (-11.29%)
Zogenix Gets Refusal to File Letter From FDA for Seizure Drug

Zogenix (ZGNX) receives a Refusal to File letter from the FDA regarding its NDA for Fintepla for the treatment of seizures associated with Dravet syndrome.

GWPH : 117.01 (+2.19%)
ZGNX : 41.90 (+2.10%)
BSTC : 50.17 (-0.14%)
ESALY : 50.7900 (-0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade ESALY with:

Key Turning Points

2nd Resistance Point 51.7367
1st Resistance Point 51.2933
Last Price 50.7900
1st Support Level 50.2033
2nd Support Level 49.5567

See More

52-Week High 96.1600
Fibonacci 61.8% 77.9615
Fibonacci 50% 72.3400
Fibonacci 38.2% 66.7185
Last Price 50.7900
52-Week Low 48.5200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar